ALTERITY THERAP LTD ORDINARY (ATH) Short Interest
ALTERITY THERAP LTD ORDINARY (ASX:ATH) had 0.15% of shares reported as short positions as of 16 May 2026, representing 16,067,646 shares. ALTERITY THERAP LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
- Short interest
- 0.15%
- Reported positions
- 16,067,646
- Industry
- Pharmaceuticals, Biotechnology & Life Sciences
- As of
- 16 May 2026
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
ATH
Alterity Therapeutics
Alterity Therapeutics Limited focuses on developing therapies to treat neurodegenerative diseases associated with aging, like Alzheimer's and Parkinson's disease. The company leverages a novel drug development platform aimed at targeting misfolded proteins. Positioned as a pioneer in this field, Alterity aims to address significant unmet needs in the neurosciences market.